DBV Technologies Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

DBV Technologies şirketinin toplam hissedar öz sermayesi $207.9M ve toplam borcu $0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $266.4M ve $58.5M dir.

Anahtar bilgiler

Borç/özkaynak oranı

US$0

Borç

Faiz karşılama oranı	n/a
Nakit	US$229.20m
Eşitlik	US$207.90m
Toplam yükümlülükler	US$58.50m
Toplam varlıklar	US$266.40m

Son finansal sağlık güncellemeleri

Analiz Makalesi • Dec 09

Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, DBV Technologies...

Recent updates

Analiz Makalesi • Dec 09

Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, DBV Technologies...

Analiz Makalesi • Jan 10

Revenues Not Telling The Story For DBV Technologies S.A. (EPA:DBV) After Shares Rise 76%

DBV Technologies S.A. ( EPA:DBV ) shareholders have had their patience rewarded with a 76% share price jump in the last...

Analiz Makalesi • Oct 24

DBV Technologies S.A.'s (EPA:DBV) 41% Share Price Surge Not Quite Adding Up

DBV Technologies S.A. ( EPA:DBV ) shareholders would be excited to see that the share price has had a great month...

Analiz Makalesi • Aug 04

Analysts Just Made A Major Revision To Their DBV Technologies S.A. (EPA:DBV) Revenue Forecasts

One thing we could say about the analysts on DBV Technologies S.A. ( EPA:DBV ) - they aren't optimistic, having just...

Analiz Makalesi • Jun 14

Risks To Shareholder Returns Are Elevated At These Prices For DBV Technologies S.A. (EPA:DBV)

It's not a stretch to say that DBV Technologies S.A.'s ( EPA:DBV ) price-to-sales (or "P/S") ratio of 6.8x seems quite...

Analiz Makalesi • May 10

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For DBV Technologies S.A.'s (EPA:DBV) CEO For Now

Key Insights DBV Technologies will host its Annual General Meeting on 16th of May Total pay for CEO Daniel Tass...

Analiz Makalesi • May 09

DBV Technologies S.A. (EPA:DBV) Released Earnings Last Week And Analysts Lifted Their Price Target To €6.50

As you might know, DBV Technologies S.A. ( EPA:DBV ) recently reported its quarterly numbers. Revenues came in at...

Analiz Makalesi • Mar 14

Some DBV Technologies S.A. (EPA:DBV) Analysts Just Made A Major Cut To Next Year's Estimates

One thing we could say about the analysts on DBV Technologies S.A. ( EPA:DBV ) - they aren't optimistic, having just...

Analiz Makalesi • Mar 10

DBV Technologies S.A. (EPA:DBV) Just Reported Earnings, And Analysts Cut Their Target Price

DBV Technologies S.A. ( EPA:DBV ) just released its latest annual results and things are looking bullish. Revenue...

Analiz Makalesi • Dec 01

Here's Why We're Not Too Worried About DBV Technologies' (EPA:DBV) Cash Burn Situation

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Analiz Makalesi • Aug 06

DBV Technologies S.A. (EPA:DBV) Shares Could Be 45% Below Their Intrinsic Value Estimate

Does the August share price for DBV Technologies S.A. ( EPA:DBV ) reflect what it's really worth? Today, we will...

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: DBV 'nin kısa vadeli varlıkları ( $246.7M ) kısa vadeli yükümlülüklerini ( $51.8M ) aşıyor.

Uzun Vadeli Yükümlülükler: DBV şirketinin kısa vadeli varlıkları ( $246.7M ) uzun vadeli yükümlülüklerini ( $6.7M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: DBV borçsuzdur.

Borcun Azaltılması: DBV şirketinin 5 yıl önce borç/öz sermaye oranı 0.6% iken borcu yok.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: DBV şirketinin mevcut serbest nakit akışına göre bir yıldan fazla yetecek nakit pisti bulunmaktadır.

Tahmini Nakit Akışı: Serbest nakit akışı her yıl % 6.8 oranında tarihsel oranda büyümeye devam ederse DBV un bir yıldan az nakit akışı süresi vardır.

Sağlıklı şirketleri keşfedin

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2026/06/17 21:43
Gün Sonu Hisse Fiyatı	2026/06/17 00:00
Kazançlar	2026/03/31
Yıllık Kazançlar	2025/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

DBV Technologies S.A. 16 Bu analistlerden 6, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Tazeen Ahmad	BofA Global Research
Kristen Kluska	Cantor Fitzgerald & Co.
Jonathan Wolleben	Citizens JMP Securities, LLC

DBV Technologies Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?

DBV Technologies S.A. announced delayed annual 10-K filing

DBV Technologies Regains Compliance with Nasdaq Listing Rule 5550(a)(2)

DBV Technologies Announces Plan to Implement ADS Ratio Change to Regain Compliance

DBV Technologies Provides Non-Compliance Update Related to Nasdaq Listing Rule 5550(a)(2) & 5810(c)(3)(A)

DBV Technologies Receives a Letter from the Listing Qualifications Staff of the Nasdaq Stock Market

Recent updates

DBV Technologies Starts Infant Peanut Allergy Trial and Reports Positive Phase 3 Results

DBV Technologies Presents New Positive Data from VITESSE Study and Previews Recently Initiated THRIVE Study at EAACI Congress 2026

DBV Technologies Screens First Participant In Thrive Phase 2 Study Of The Viaskin Peanut Patch In Infants With Peanut Allergy

DBV Technologies Reports Q1 Loss as Viaskin Peanut Patch Nears 2026 FDA Submissions

Consensus revenue estimates decrease by 14%

First quarter 2026 earnings released: US$0.11 loss per share (vs US$0.26 loss in 1Q 2025)

DBV Technologies S.A., Annual General Meeting, Jun 03, 2026

DBV Technologies S.A. to Report Q3, 2026 Results on Oct 28, 2026

Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behind

Forecast to breakeven in 2028

Dbv Technologies Highlights Additional Data from Successful Phase 3 Vitesse Study At the Aaaai 2026 Annual Meeting

Price target increased by 116% to €3.29

Consensus revenue estimates decrease by 10%

Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?

Consensus revenue estimates decrease by 14%, EPS upgraded

DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial, Effective November 3, 2025

New major risk - Financial position

DBV Technologies Announces Resignation of Daniel Soland as a Member of its Board of Directors, Effective September 18, 2025

DBV Technologies S.A. has filed a Follow-on Equity Offering in the amount of $150 million.

Consensus EPS estimates upgraded to US$0.86 loss

Consensus revenue estimates increase by 33%

Second quarter 2025 earnings released: US$0.31 loss per share (vs US$0.34 loss in 2Q 2024)

DBV Technologies S.A. Announces Executive Changes

Price target decreased by 38% to €1.52

Insufficient new directors

DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 - 3 Years Old

DBV Technologies S.A., Annual General Meeting, Jun 11, 2025

DBV Technologies S.A. announced delayed annual 10-K filing

Full year 2024 earnings released: US$1.17 loss per share (vs US$0.77 loss in FY 2023)

Revenues Not Telling The Story For DBV Technologies S.A. (EPA:DBV) After Shares Rise 76%

New minor risk - Shareholder dilution

DBV Technologies Regains Compliance with Nasdaq Listing Rule 5550(a)(2)

DBV Technologies Announces Plan to Implement ADS Ratio Change to Regain Compliance

Third quarter 2024 earnings released: US$0.32 loss per share (vs US$0.17 loss in 3Q 2023)

DBV Technologies S.A.'s (EPA:DBV) 41% Share Price Surge Not Quite Adding Up

New major risk - Revenue and earnings growth

Dbv Technologies Announces Positive Regulatory Updates for the Viaskin Peanut Patch in the United States and Europe

Price target decreased by 48% to €2.45

Consensus revenue estimates decrease by 18%

Analysts Just Made A Major Revision To Their DBV Technologies S.A. (EPA:DBV) Revenue Forecasts

Second quarter 2024 earnings released: US$0.34 loss per share (vs US$0.26 loss in 2Q 2023)

DBV Technologies S.A. to Report Q2, 2024 Results on Jul 30, 2024

New minor risk - Share price stability

DBV Technologies Provides Non-Compliance Update Related to Nasdaq Listing Rule 5550(a)(2) & 5810(c)(3)(A)

Risks To Shareholder Returns Are Elevated At These Prices For DBV Technologies S.A. (EPA:DBV)

Consensus EPS estimates upgraded to US$0.74 loss, revenue downgraded

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For DBV Technologies S.A.'s (EPA:DBV) CEO For Now

DBV Technologies S.A. (EPA:DBV) Released Earnings Last Week And Analysts Lifted Their Price Target To €6.50

Price target increased by 36% to €6.50

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

New major risk - Revenue and earnings growth

No longer forecast to breakeven

Insufficient new directors

DBV Technologies S.A., Annual General Meeting, May 16, 2024

New minor risk - Profitability

No longer forecast to breakeven

Some DBV Technologies S.A. (EPA:DBV) Analysts Just Made A Major Cut To Next Year's Estimates

DBV Technologies S.A. (EPA:DBV) Just Reported Earnings, And Analysts Cut Their Target Price

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Price target decreased by 17% to €4.43

New major risk - Financial position

DBV Technologies S.A. to Report Fiscal Year 2023 Results on Mar 07, 2024

Forecast to breakeven in 2026

DBV Technologies Receives a Letter from the Listing Qualifications Staff of the Nasdaq Stock Market

Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?

DBV Technologies S.A. to Present New Data at ACAAI 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Consensus revenue estimates increase by 29%

DBV Technologies S.A. to Report Q3, 2023 Results on Oct 31, 2023